Sökresultat - Moog C

  • Visas 1 - 8 av 8 resultat
Förfina resultatet
Lista   Rutsystem  
  1. 1

    P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells av Penichon J, Decoville T, Holl V, Delaporte M, Moog C

    Utgiven 2009-10-01
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2

    P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection av Moog C, Schmidt S, Decoville T, Penichon J, Lederle A, Holl V

    Utgiven 2009-10-01
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3

    Anti-HIV and immune modulating activities of IND02 av Biedma ME, Connell B, Schmidt S, Lortat-Jacob H, Moog C, Prakash E

    Utgiven 2012-09-01
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4

    P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes av Aubertin A, Schmidt S, Decoville T, Peressin M, Holl V, Xu K, Moog C

    Utgiven 2009-10-01
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5

    P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection av Lopalco L, Reynes J, Moog C, Drillet A, Diomede L, Houimel M, Derrien M, Tudor D, Bomsel M

    Utgiven 2009-10-01
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6

    Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates av Moog C, Dereuddre-Bosquet N, Biedma M, Schmidt S, Decoville T, Mangeot I, Zolla-Pazner S, Vcelar B, Katinger D, Holl V, Le Grand R

    Utgiven 2012-09-01
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7

    P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group av Polonis V, Osmanov S, Morris L, Moog C, Montefiori D, Malnati M, Lopalco L, Jansson M, Holmes H, Heyndrickx L, Heath A, Fenyö E, Bongertz V, Alcami J, Scarlatti G, Ramaswamy M, Sattentau Q, Schuitemaker H, Wrin T

    Utgiven 2009-10-01
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8

    Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans av Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R

    Utgiven 2012-09-01
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: